Stringent quality control measures ensure the safety, purity,
and consistency of immunoglobulin products, fostering trust and
confidence among stakeholders.
WILMINGTON, Del., July 16, 2024 /PRNewswire/ -- The global
immunoglobulins market is estimated to flourish at a CAGR
of 6.2% from 2023 to 2031. Transparency Market Research
projects that the overall sales revenue for immunoglobulins is
estimated to reach US$ 27.7
billion by the end of 2031.
A significant driver is the increasing awareness and acceptance
of immunoglobulin therapies among healthcare professionals and
patients. As understanding of immunoglobulin treatments improves,
more healthcare providers are recommending them for a broader range
of conditions, leading to increased demand and market growth.
The development of novel administration methods for
immunoglobulin therapies presents an opportunity for market
expansion. Innovations such as subcutaneous infusion devices and
improved formulations enhance patient convenience, compliance, and
outcomes, driving adoption rates and market penetration.
Grab Your Sample Report Here:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=52353
Regulatory harmonization across regions streamlines approval
processes and facilitates market entry for manufacturers, fostering
competition and innovation in the immunoglobulins sector.
Patient advocacy and support groups play a crucial role in
driving awareness, education, and access to immunoglobulin
therapies. Their efforts in promoting understanding, advocating for
improved access, and addressing patient concerns contribute to
market growth and patient empowerment.
Key Findings of the Market Report
- Immunology leads the immunoglobulins market, addressing various
autoimmune disorders and immunodeficiency diseases with specialized
therapeutic solutions and treatments.
- Intravenous route of administration leads the immunoglobulins
market, ensuring direct and efficient delivery of therapeutic
antibodies for various medical conditions.
- Hospitals lead the immunoglobulins market, serving as primary
centers for diagnosis, treatment, and administration of
immunoglobulin therapies to patients.
Immunoglobulins Market Growth Drivers & Trends
- Growing incidence of immunodeficiency disorders and autoimmune
diseases fuels demand for immunoglobulin therapies globally.
- Ongoing research and development efforts enhance product
efficacy, safety, and convenience, fostering market growth.
- Increasing therapeutic applications of immunoglobulins beyond
primary immunodeficiencies to neurological and autoimmune disorders
drive market diversification.
- Asia Pacific showcases rapid
market growth, driven by healthcare infrastructure development,
rising disease awareness, and increasing patient access to
immunoglobulin therapies.
- Key players engage in strategic partnerships, collaborations,
and acquisitions to strengthen market foothold, drive innovation,
and expand global presence.
Immunoglobulins Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2023-2031
|
Base
Year
|
2017-2021
|
Size in 2023
|
US$ 16.3 Bn
|
Forecast (Value) in
2031
|
US$ 27.7 Bn
|
Growth Rate
(CAGR)
|
6.2 %
|
No. of
Pages
|
188
Pages
|
Segments
covered
|
By Application, By
Route of Administration, By End-user, By Region
|
Global Immunoglobulins Market: Regional Profile
- In North America, a
mature market, rigorous research and development efforts by key
players like CSL Behring and Grifols drive market growth. High
healthcare expenditure and favorable reimbursement policies further
bolster market expansion, ensuring widespread access to
immunoglobulin therapies.
- In Europe, stringent
regulatory standards and a robust healthcare system foster
innovation and quality assurance in the immunoglobulins sector.
Companies such as Octapharma and Kedrion lead the market, catering
to diverse therapeutic needs and ensuring patient safety and
efficacy.
- Asia Pacific emerges as
a rapidly growing market propelled by increasing healthcare
investments and rising disease burden. Countries like Japan and China witness significant demand for
immunoglobulin therapies, driven by the growing prevalence of
immunodeficiency disorders and autoimmune diseases. Local players
like Biotest AG and GC Pharma seize opportunities, offering
tailored solutions and expanding market reach.
Unlock Growth Potential in Immunoglobulins
Industry! Download PDF Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=52353
Immunoglobulins Market: Competitive Landscape
The immunoglobulins market is fiercely competitive, driven by
robust research, stringent quality standards, and global demand for
immunotherapy. Leading players such as CSL Behring, Grifols, and
Octapharma dominate, offering diverse portfolios of immunoglobulin
products catering to various therapeutic indications.
Emerging contenders like Kedrion and Biotest AG intensify
competition, innovating with novel formulations and expanding
market presence. Regulatory compliance, technological advancements,
and strategic collaborations shape the competitive landscape,
driving product differentiation and market expansion. With rising
prevalence of immunodeficiency disorders and autoimmune diseases,
the immunoglobulins market remains dynamic, fostering innovation
and excellence in therapeutic solutions. Some prominent players are
as follows:
- Shire
- CSL Behring
- Kedrion Biopharma Inc.
- Grifols S.A.
- Octapharma
- China Biologic Products Holdings Inc.
- Biotest AG
- Sanquin
- LFB SA
Product Portfolio
- Biotest AG pioneers innovative solutions in immunology and
hematology, offering a comprehensive portfolio of plasma-derived
and recombinant therapeutic proteins. Their commitment to
scientific excellence and patient well-being drives advancements in
transfusion medicine, immunology, and critical care.
- Sanquin leads with expertise in blood banking, diagnostics, and
pharmaceuticals, delivering lifesaving blood products and
diagnostics solutions. Their dedication to research and
collaboration ensures safe, efficient, and accessible healthcare
services worldwide.
- LFB SA specializes in biopharmaceuticals, producing
plasma-derived medicinal products and innovative therapies for rare
diseases. With a focus on quality, safety, and patient-centricity,
LFB SA advances healthcare solutions, addressing unmet medical
needs and improving patient outcomes globally.
Immunoglobulins Market: Key Segments
By Application
- Neurology
- Immunology
- Hematology
- Others
By Route of Administration
- Intravenous
- Subcutaneous
- Intramuscular
By End User
- Hospitals
- Clinics
- Homecare
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=52353<ype=S
More Trending Reports by Transparency Market Research
–
- Sinusitis Treatment Market - The global sinusitis
treatment market is projected to flourish at a CAGR of 5.8%
from 2023 to 2031. As per the report published by TMR, a valuation
of US$ 3.5 Bn is anticipated
for the market in 2031.
- Biological Imaging Reagents Market - The global
biological imaging reagents market is projected to grow at a CAGR
of 5.4% from 2023 to 2031.
- Hypersensitivity Pneumonitis Market - Rapid
globalization and industrialization has resulted in more number of
people getting exposed to various environmental hazards, thereby
resulting in higher prevalence of hypersensitivity
pneumonitis.
- Bipolar Disorder Treatment Market - Bipolar Disorder
Treatment Market is expected to grow at a CAGR of 5.4% from 2024 to
2034 and reach US$ 9.2 Bn by the end
of 2034
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE
HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter|
Blog | YouTube
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/immunoglobulins-market-size--share-to-surpass-usd-27-7-billion-by-2031--projected-a-cagr-of-6-2--report-by-transparency-market-research-inc-302198108.html